ArticlePloS one2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
Oren J Becher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled itcites it